CC chemokine receptors and chronic inflammation—therapeutic opportunities and pharmacological challenges

GE White, AJ Iqbal, DR Greaves - Pharmacological reviews, 2013 - ASPET
Chemokines are a family of low molecular weight proteins with an essential role in leukocyte
trafficking during both homeostasis and inflammation. The CC class of chemokines consists …

[HTML][HTML] Chemokines and chemokine receptors in arthritis

Z Szekanecz, A Vegvari, Z Szabo… - Frontiers in bioscience …, 2010 - ncbi.nlm.nih.gov
Chemokines are involved in leukocyte recruitment to inflammatory sites, such as the
synovial tissue in rheumatoid arthritis (RA). There is a structural and a functional …

[PDF][PDF] Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components

X Chen, JJ Oppenheim, OM Howard - Cell Mol Immunol, 2004 - cmi.ustc.edu.cn
Chemokines are chemoattractant cytokines that direct the migration of leukocytes, and are
induced by inflammatory cytokines, growth factors and pathogenic stimuli (1). Chemokines …

Can we target CCR2 to treat osteoarthritis? The trick is in the timing!

RE Miller, AM Malfait - Osteoarthritis and cartilage, 2017 - oarsijournal.com
CeC motif chemokines, including CCL2, CCL7, and CCL12, affect cells that express the
CeC chemokine receptor type 2, CCR2, a seven-transmembrane domain G-protein coupled …

Rheumatoid arthritis: pathogenesis and therapeutic advances

Y Gao, Y Zhang, X Liu - MedComm, 2024 - Wiley Online Library
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by the unresolved
synovial inflammation for tissues‐destructive consequence, which remains one of significant …

Promising therapeutic targets for treatment of rheumatoid arthritis

J Huang, X Fu, X Chen, Z Li, Y Huang… - Frontiers in …, 2021 - frontiersin.org
Rheumatoid arthritis (RA) is a systemic poly-articular chronic autoimmune joint disease that
mainly damages the hands and feet, which affects 0.5% to 1.0% of the population …

Therapeutic inhibition of leukocyte recruitment in inflammatory diseases

Z Szekanecz, AE Koch - Current Opinion in Pharmacology, 2004 - Elsevier
The ingress of leukocytes into sites of inflammation is crucial for the pathogenesis of arthritis
and other inflammatory conditions. Chemokines, their receptors and cellular adhesion …

Signaling pathways in rheumatoid arthritis: implications for targeted therapy

Q Ding, W Hu, R Wang, Q Yang, M Zhu, M Li… - Signal transduction and …, 2023 - nature.com
Rheumatoid arthritis (RA) is an incurable systemic autoimmune disease. Disease
progression leads to joint deformity and associated loss of function, which significantly …

Old drugs with new skills: fenoprofen as an allosteric enhancer at melanocortin receptor 3

T Montero-Melendez, RAE Forfar, JM Cook… - Cellular and Molecular …, 2017 - Springer
The efficiency of drug research and development has paradoxically declined over the last
decades despite major scientific and technological advances, promoting new cost-effective …

Targeting granulocyte-monocyte colony-stimulating factor signaling in rheumatoid arthritis: future prospects

C Crotti, E Agape, A Becciolini, M Biggioggero… - Drugs, 2019 - Springer
Rheumatoid arthritis (RA) is a systemic, autoimmune disease that affects joints and extra-
articular structures. In the last decade, the management of this chronic disease has …